Rules/misleading presentation/US-MIS-042

Use risk language comprehensible to the same audience as benefit language

AI-verifiedwarningFDA guidance · non-bindingRaised as a question — a person decides

Rule

The reading/comprehension level of the language used for risk statements should match the language used for benefit statements, appropriate to the intended audience.

Check

Compare vocabulary and technical complexity of risk statements against benefit statements; flag risk language that is markedly more technical or harder to understand than the benefit language aimed at the same audience.

Escalate when

When it is unclear whether the audience (consumer vs. HCP) would understand the risk terminology used.

Where this comes from

Section III.A.1, Consistent Use of Language · page 10. The highlighted words are quoted exactly; a script confirms they appear in the source before the rule can be published.

…ng whether risk information is communicated in a fashion consistent with the regulations. A. GENERAL CONSIDERATIONS This section explores some important factors that relate to both the content and the format of a promotional piece. FDA will consider the use of language and signals and how information is framed and ordered. 1. Consistent Use of Language Appropriate for Target Audience Both language used to communicate benefits and language used to communicate risks should be comprehensible to the same audience for a piece to be considered accurate and non-misleading. Thus, promotional materials directed to professionals can reasonably describe benefits and risks in medical language, but promotional materials directed to consumers should convey benefits and risks in language understandable to consumers. > Example 3: A consumer-directed ad for a drug that presents benefit claims in consumer friendly > language should mention a risk of “fainting,” not “syncope.” With respect …

Open the original at page 10 on fda.gov ↗Read our full copy →

Document: FDA guidance: Presenting Risk Information in Prescription Drug and Medical Device Promotion (see document)
Version: as retrieved — the publisher does not version this document; the fingerprint below identifies the exact file
Retrieved: 2026-09-21 from www.fda.gov
Fingerprint: f5654ab082f6cd4408143f16…

FDA guidance describes the agency's current thinking. It is not binding law, and this rule is a recommendation, not an obligation.

Applies when

Naturepromotional

How this rule was checked

Citation proven by script and passed an independent verifier running on a different model. Not yet confirmed by a human.

Drafted
claude-code:sonnet · 2026-09-21
Independent verification — pass
claude-code:opus · 2026-09-21
Reviewer's reasons
- The quote is a complete sentence and states the requirement directly: both benefit language and risk language 'should be comprehensible to the same audience for a piece to be considered accurate and non-misleading'.
- The rule's audience-relative framing is the source's own: 'promotional materials directed to professionals can reasonably describe benefits and risks in medical language, but promotional materials directed to consumers should convey benefits and risks in language understandable to consumers', illustrated by Example 3 ('fainting', not 'syncope').
- The check is correctly directional — it flags risk language that is markedly more technical or harder to understand than the benefit language aimed at the same audience, which is the asymmetry the source is concerned with; risk language that is plainer than the benefit language is not flagged.
- Not overstated: 'should' is preserved and no obligation is asserted. Atomic: one comprehensibility comparison.
- Judgment determinism is correct — comprehensibility to a given audience is an assessment, as the escalation trigger recognizes.
- applies_when (promotional, unscoped by medium) matches the guidance's statement that its principles apply to all promotional pieces regardless of medium or target audience; the locator 'Section III.A.1, Consistent Use of Language' is right; authority and 'warning' severity are defensible.
Revised by the drafter
claude-code:sonnet · 2026-09-21
Independent verification — pass
claude-code:opus · 2026-09-21
Reviewer's reasons
- The quote is the complete opening sentence of Section III.A.1 and directly states that benefit and risk language should be comprehensible to the same audience; the rule keeps 'should' and adds nothing beyond it.
- Example 3 ('fainting' vs 'syncope') and the HCP/consumer contrast in the next sentence support the check comparing technicality of risk vs benefit language for the target audience.
- Comprehensibility is an impression call, so judgment is correct; warning severity and the promotional-only scope are defensible; the locator matches the heading (shortened title of III.A.1).